CDC Report: HIV Prevention Pill Widely Underused; Alabama Communities at Risk

Why it matters locally: A new CDC report highlighting the underutilization of PrEP (pre-exposure prophylaxis), a crucial HIV prevention medication, carries significant implications for Alabama. With a population of over 5 million, any shortfall in preventative healthcare measures can lead to heightened rates of HIV infection, particularly within vulnerable demographics. Resource allocation towards public health and education hinges on such analysis.

---

Denver, CO - A new analysis released by the Centers for Disease Control and Prevention (CDC) indicates that pre-exposure prophylaxis (PrEP), a medication used to prevent HIV infection, is not being utilized by a significant portion of the at-risk population in the United States. The findings were presented at the 2018 Conference on Retroviruses and Opportunistic Infections. The CDC analysis highlights that disparities exist in PrEP access and uptake, with people of color being disproportionately affected. Data suggests that a considerable number of individuals who could benefit from PrEP are not receiving or utilizing the medication. Further details regarding the specific methodology of the CDC analysis, the size and demographics of the study population, and specific data points on PrEP usage rates were not immediately available. Further information is expected to be released by the CDC in the near future.